Abstract:Background & Aims: Gastric cancer is the most frequent gastrointestinal tumor in adults and is the most lethal form of human cancer. Despite of the improvements in treatments, the underlying mechanism of gastric carcinogenesis is not well known. To define novel modulators that regulate susceptibility to tumorgenesis, we focused on miR-219-2-3p.Methods: Quantitative RT-PCR was employed to investigate the level of miR-219-2-3p in gastric cancer (GC) tissues (n = 113) and their matched adjacent normal tissues (n = 113). In vitro cell proliferation, apoptosis assays, cell migration, and invasion assays were performed to elucidate biological effects of miR-219-2-3p. Since silencing of miRNA by promoter CpG island methylation may be an important mechanism in tumorgenesis, GC cells were treated with 5-aza-2'-deoxycytidine and trichostatin A, and expression changes of miR-219-2-3p were subsequently examined by quantitative RT-PCR. Finally, the methylation status of CpG island upstream of miR-219-2-3p was analyzed by methylation-specific PCR in GC tissues (n = 22).Results: miR-219-2-3p was down-regulated in GC and cell lines. In addition, the experiments documented the lower expression of miR-219-2-3p in GC specimens with higher grade and later stage tumors. Meanwhile, miR-219-2-3p exerted antiproliferative, proapoptotic, and antimetastatic roles and reduced levels of p-ERK1/2 in GC cells. Furthermore, 5-aza-2'-deoxycytidine and trichostatin A increased the expression (similar to 2 fold) of miR-219-2-3p in GC cells. By methylation-specific PCR, DNA methylation in the upstream region of miR-219-2-3p was detected in both adjacent normal tissues and cancer tissues. As expected, the methylation level was considerably higher in the miR-219-2-3p down-regulated group than up-regulated group.Conclusions: miR-219-2-3p is potentially involved in gastric cancer progression and metastasis by regulating ERK1/2-related signal pathways, which may provide a novel therapeutic strategy for treatment of gastric cancer. Methylation mechanism may be involved in modulating the expression level of miR-219-2-3p in gastric cancer.

DNMT1 and EZH2 Mediated Methylation Silences the Microrna-200B/a/429 Gene and Promotes Tumor Progression.

Dnmt1 Mediates Chemosensitivity By Reducing Methylation Of Mirna-20a Promoter In Glioma Cells

Transcriptional Repression of Mir-200 Family Members by Nanog in Colon Cancer Cells Induces Epithelial Mesenchymal Transition (Emt)

Epigenetically Deregulated Mir-200C is Involved in a Negative Feedback Loop with DNMT3a in Gastric Cancer Cells.

The Downregulation of Mir-200C/141 Promotes ZEB1/2 Expression and Gastric Cancer Progression

DNMT1 Recruited by EZH2-mediated Silencing of Mir-484 Contributes to the Malignancy of Cervical Cancer Cells Through MMP14 and HNF1A

Epigenetic silencing of miR 137 in gastric cancer

MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

MYC and DNMT3A‐mediated DNA Methylation Represses Microrna‐200b in Triple Negative Breast Cancer

Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.

Methylation-induced Downregulation and Tumor-Suppressive Role of Microrna-98 in Glioma Through Targeting Sal-like Protein 4

Microrna-342 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Directly Targeting Dna Methyltransferase 1

MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation

Reduced Expression of Microrna-432-5p by DNA Methyltransferase 3B Leads to Development of Colorectal Cancer Through Upregulation of CCND2

Methylation-mediated Repression of Microrna-129-2 Suppresses Cell Aggressiveness by Inhibiting High Mobility Group Box 1 in Human Hepatocellular Carcinoma.

Downregulated Microrna-200a Promotes Emt And Tumor Growth Through The Wnt/Beta-Catenin Pathway By Targeting The E-Cadherin Repressors Zeb1/Zeb2 In Gastric Adenocarcinoma

Methylation-mediated Repression of Potential Tumor Suppressor Mir-203A and Mir-203B Contributes to Esophageal Squamous Cell Carcinoma Development

Mir-200B and Mir-200C As Prognostic Factors and Mediators of Gastric Cancer Cell Progression.

Microrna-219-2-3p Functions As A Tumor Suppressor In Gastric Cancer And Is Regulated By Dna Methylation

Deregulation Between Mir-29B/c and DNMT3A is Associated with Epigenetic Silencing of the CDH1 Gene, Affecting Cell Migration and Invasion in Gastric Cancer